Literature DB >> 22258188

Involvement of globus pallidus and midbrain nuclei in pantothenate kinase-associated neurodegeneration: measurement of T2 and T2* time.

R Fermin-Delgado1, P Roa-Sanchez, H Speckter, E Perez-Then, D Rivera-Mejia, B Foerster, P Stoeter.   

Abstract

PURPOSE: To quantify involvement of globus pallidus and two midbrain nuclei (substantia nigra and red nucleus) in Pantothenate Kinase-Associated Neurodegeneration (PKAN).
MATERIAL AND METHODS: We performed T2 and T2* weighted imaging with calculation of the corresponding relaxation times on a subset of 5 patients from a larger group of 20 patients with PKAN from the southwest part of the Dominican Republic. Examinations were carried out on a 3T scanner and included a multi-echo spin-echo as well as a multi-echo gradient echo sequence. Results were compared to a control group of 19 volunteers.
RESULTS: T2 and T2* weighted sequences showed abnormal signal reduction in the globus pallidus of all patients. On T2* weighted imaging, abnormal signal in the substantia nigra could reliably be detected in 75% of cases, but differentiation from normal was less reliable in T2 weighted scans. Correspondingly, relaxation times differed from normal with very high significance (p < 0.0001) in the globus pallidus, but with with less significance in the substantia nigra (p ≤ 0.03). The red nucleus was not affected.
CONCLUSIONS: Signal reduction in the globus pallidus, which probably is due to abnormal accumulation of iron, is severe in PKAN and can be differentiated from normal with high reliability. The substantia nigra is affected to a lesser degree, and the red nucleus is not involved. The reason for this selective susceptibility of normally iron-rich brain structures for pathological accumulation of iron remains speculative. Our quantitative results might be helpful to assess the value of an iron chelation approach to therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22258188     DOI: 10.1007/s00062-011-0127-9

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  26 in total

Review 1.  Imaging iron stores in the brain using magnetic resonance imaging.

Authors:  E Mark Haacke; Norman Y C Cheng; Michael J House; Qiang Liu; Jaladhar Neelavalli; Robert J Ogg; Asadullah Khan; Muhammad Ayaz; Wolff Kirsch; Andre Obenaus
Journal:  Magn Reson Imaging       Date:  2005-01       Impact factor: 2.546

2.  Volume and iron content in basal ganglia and thalamus.

Authors:  Patrice Péran; Andrea Cherubini; Giacomo Luccichenti; Gisela Hagberg; Jean-François Démonet; Olivier Rascol; Pierre Celsis; Carlo Caltagirone; Gianfranco Spalletta; Umberto Sabatini
Journal:  Hum Brain Mapp       Date:  2009-08       Impact factor: 5.038

3.  Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects.

Authors:  Domenico Aquino; Alberto Bizzi; Marina Grisoli; Barbara Garavaglia; Maria Grazia Bruzzone; Nardo Nardocci; Mario Savoiardo; Luisa Chiapparini
Journal:  Radiology       Date:  2009-07       Impact factor: 11.105

4.  MRI of brain iron.

Authors:  B Drayer; P Burger; R Darwin; S Riederer; R Herfkens; G A Johnson
Journal:  AJR Am J Roentgenol       Date:  1986-07       Impact factor: 3.959

5.  The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration.

Authors:  J Vymazal; M Hajek; N Patronas; J N Giedd; J W Bulte; C Baumgarner; V Tran; R A Brooks
Journal:  J Magn Reson Imaging       Date:  1995 Sep-Oct       Impact factor: 4.813

6.  MR relaxometry and 1H MR spectroscopy for the determination of iron and metabolite concentrations in PKAN patients.

Authors:  Milan Hájek; Miriam Adamovicová; Vít Herynek; Antonín Skoch; Filip Jírů; Anna Krepelová; Monika Dezortová
Journal:  Eur Radiol       Date:  2004-11-24       Impact factor: 5.315

7.  Relevance of Iron Deposition in Deep Gray Matter Brain Structures to Cognitive and Motor Performance in Healthy Elderly Men and Women: Exploratory Findings.

Authors:  Edith V Sullivan; Elfar Adalsteinsson; Torsten Rohlfing; Adolf Pfefferbaum
Journal:  Brain Imaging Behav       Date:  2009-06-01       Impact factor: 3.978

8.  T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.

Authors:  A McNeill; D Birchall; S J Hayflick; A Gregory; J F Schenk; E A Zimmerman; H Shang; H Miyajima; P F Chinnery
Journal:  Neurology       Date:  2008-04-29       Impact factor: 9.910

9.  Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.

Authors:  Frederik Clement; David Devos; Caroline Moreau; Philippe Coubes; Alain Destee; Luc Defebvre
Journal:  Acta Neurol Belg       Date:  2007-03       Impact factor: 2.396

10.  Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus.

Authors:  T L Perry; M G Norman; V W Yong; S Whiting; J U Crichton; S Hansen; S J Kish
Journal:  Ann Neurol       Date:  1985-10       Impact factor: 10.422

View more
  8 in total

1.  A Novel Deletion Mutation of Exon 2 of the C19orf12 Gene in an Omani Family with Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN).

Authors:  Nabil Al Macki; Ismail Al Rashdi
Journal:  Oman Med J       Date:  2017-01

2.  Pathophysiology and treatment of neurodegeneration with brain iron accumulation in the pediatric population.

Authors:  Susanne A Schneider; Giovanna Zorzi; Nardo Nardocci
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598

Review 3.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

Review 4.  Neurodegeneration with Brain Iron Accumulation.

Authors:  Susanne A Schneider
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

Review 5.  Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  J Neural Transm (Vienna)       Date:  2012-12-02       Impact factor: 3.575

6.  7-Tesla Magnetic Resonance Imaging for Brain Iron Quantification in Homozygous and Heterozygous PANK2 Mutation Carriers.

Authors:  Petr Dusek; Elena Maria Tovar Martinez; Vince Istvan Madai; Robert Jech; Jan Sobesky; Friedemann Paul; Thoralf Niendorf; Jens Wuerfel; Susanne A Schneider
Journal:  Mov Disord Clin Pract       Date:  2014-10-23

7.  Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA).

Authors:  Susanne A Schneider; Petr Dusek; John Hardy; Ana Westenberger; Joseph Jankovic; Kailash P Bhatia
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

Review 8.  New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases.

Authors:  Marco T Nuñez; Pedro Chana-Cuevas
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.